Viri Sode Spray
NDC Package 83027-0150-1
Package Information
Viri Sode (cytomegalovirus nosode, herpes simplex i nosode, herpes simplex ii nosode, influenzinum (2024-2025), rubella nosode, hepatitis a nosode, hepatitis b nosode, hepatitis c nosode, epstein barr virus nosode, herpes zoster nosode) sprays is • Adults: 2 to 3 sprays orally, three times daily.• Children under twelve one half adult dosage. For highly sensitive individuals: best tolerated administration is through imbrication (RUBBING IN) on skin at pulse points or abdomen.• Do not take within 15 minutes of consuming food, beverage or brushing teeth.Consult a physician for use in children under 12 years of age. This formulation utilizes a spray delivery system. Marketed by Nutritional Specialties, Inc., this product is identified by NDC 83027-0150.
Identification & Billing
Clinical Specifications
- HEPATITIS A VIRUS 30 [hp_X]/mL
- HEPATITIS B VIRUS 30 [hp_X]/mL
- HEPATITIS C VIRUS 30 [hp_X]/mL
- HUMAN HERPESVIRUS 1 16 [hp_X]/mL
- HUMAN HERPESVIRUS 2 16 [hp_X]/mL
- HUMAN HERPESVIRUS 3 15 [hp_C]/mL
- HUMAN HERPESVIRUS 4 15 [hp_C]/mL
- HUMAN HERPESVIRUS 5 16 [hp_X]/mL
- INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 15 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 15 [hp_C]/mL
- RUBELLA VIRUS 16 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 83027 - Nutritional Specialties, Inc.
- 83027-0150 - Viri Sode
- 83027-0150-1 - 60 mL in 1 BOTTLE, SPRAY
- 83027-0150 - Viri Sode
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83027-0150-1 identifies a specific commercial package of 60 ml in 1 bottle, spray of Viri Sode, a human over the counter drug labeled by Nutritional Specialties, Inc.. This spray is formulated for oral use and contains hepatitis a virus; hepatitis b virus; hepatitis c virus; human herpesvirus 1; human herpesvirus 2; human herpesvirus 3; human herpesvirus 4; human herpesvirus 5; influenza a virus a/thailand/8/2022 ivr-237 (h3n2) antigen (formaldehyde inactivated); influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated); influenza b virus b/austria/1359417/2021 bvr-26 whole; influenza b virus b/phuket/3073/2013 bvr-1b whole; rubella virus as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nutritional Specialties, Inc. on June 03, 2025.
How is this Nutritional Specialties, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83027015001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.